5 Best Biotech ETFs To Buy

1. Franklin Genomic Advancements ETF (BATS:HELX)

5-Year Share Price Performance as of April 2: 33.33%

Franklin Genomic Advancements ETF (BATS:HELX) ranks 1st on our list of the best biotech ETFs. It is an actively managed ETF that aims for capital appreciation by investing in companies involved in genomic-based technologies, targeting improved quality of life. It focuses on firms benefiting from or enabling advancements like DNA sequencing, gene editing, and personalized medicine. The fund was established on February 25, 2020, and its reference benchmark is the Russell 3000 Index. As of April 2, 2024, Franklin Genomic Advancements ETF (BATS:HELX) owns $9.62 million in net assets, and the fund features an expense ratio of 0.50%. Its portfolio consists of 65 stocks. 

Medpace Holdings, Inc. (NASDAQ:MEDP) occupies the top position in Franklin Genomic Advancements ETF (BATS:HELX)’s portfolio. Medpace Holdings, Inc. (NASDAQ:MEDP) offers clinical research-based drug and medical device development services globally. On February 12, the company reported a Q4 GAAP EPS of $2.46 and a revenue of $498.4 million, outperforming Wall Street estimates by $0.24 and $0.63 million, respectively. 

According to Insider Monkey’s fourth quarter database, 38 hedge funds were bullish on Medpace Holdings, Inc. (NASDAQ:MEDP), compared to 36 funds in the last quarter. 

ClearBridge SMID Cap Growth Strategy stated the following regarding Medpace Holdings, Inc. (NASDAQ:MEDP) in its fourth quarter 2023 investor letter:

“We used the fourth quarter as a period of reflection and evaluation, eliminating positions where we felt our thesis was weakening while adding to new and existing holdings we felt were positioned well for years to come. Ultimately, this resulted in us initiating four new positions and exiting four others.

We also initiated a new position in Medpace Holdings, Inc. (NASDAQ:MEDP), in the health care sector, which provides clinical research-based drug and medical device development services. Medpace is a full service, one-stop shop for emergent biotech customers, and the company’s specific customer focus should allow it to continue to capture and grow market share within the industry.”

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out 10 Best Real Estate ETFs To Buy Now and 11 Best EV Stocks To Buy For The Long Term.